Daniel Graifman

Daniel Graifman is the Managing Member of Thylacine Capital and founder of Thylacine Biotherapeutics. He has extensive experience in investment analysis and operations in early stage technology companies. He is currently the President of Thylacine Bio, a biotech startup developing peptide-based therapeutics. Prior to Thylacine Bio, he served as a consultant for the Harvard Life Lab, working with diagnostic startups on pharmaceutical partnerships and competitive positioning.

Daniel previously led strategic partnerships for Swift Navigation, a deep tech autonomous vehicle firm, and launched markets for DoorDash, a consumer logistics service.

Daniel has an MBA from Harvard Business School where he was a Rock Venture Partner, and received a B.A. from Stanford University where he was a Mayfield Fellow.

‍